- What is BioMarCare's primary focus?
- BioMarCare specializes in tumor biomarker technologies for the early diagnosis of cancer, utilizing multi-biomarker panels for molecular blood tests and tissue-based diagnostic (IHC) tests.
- What is the status of BioMarCare?
- BioMarCare is currently inactive, having ceased operations in August 2020.
- When was BioMarCare founded?
- BioMarCare was founded in January 2002.
- What is Colon-MarCarePlex?
- Colon-MarCarePlex is BioMarCare's accurate, patient-friendly colorectal cancer screening test. It is a molecular assay (qRT-PCR) that measures the expression of several genes to detect advanced adenoma polyps and early-stage colorectal cancer.
- What is MCRC-Strat?
- MCRC-Strat is BioMarCare's semi-quantitative IHC assay that uses a protein biomarker combination to predict patient responses to drugs targeting the epidermal growth factor receptor. It is being developed in collaboration with a U.S. partner.
- What was BioMarCare's last known funding round?
- BioMarCare's last known funding round was in March 2012, raising $1,000,000 from Micromedic.
- How much total funding has BioMarCare raised?
- BioMarCare has raised a total of $1,900,000.
- What is BioMarCare's employee count?
- BioMarCare has 1-10 employees.